This HTML5 document contains 137 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n6http://dx.doi.org/10.1186/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n11https://scigraph.springernature.com/pub.10.1186/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33821379
rdf:type
wikibase:Item
schema:description
2011年论文 2011年論文 บทความทางวิทยาศาสตร์ scientific article наукова стаття, опублікована в лютому 2011 სამეცნიერო სტატია vetenskaplig artikel научни чланак 2011 nî lūn-bûn vitenskapelig artikkel 2011年論文 2011년 논문 artikulong pang-agham 2011年论文 tieteellinen artikkeli article scientifique (publié 2011) mokslinis straipsnis article scientific مقالهٔ علمی научная статья videnskabelig artikel (udgivet 2011) vědecký článek articolo scientifico 2011年の論文 artículo científico publicado en 2011 wissenschaftlicher Artikel article científic 2011年论文 επιστημονικό άρθρο научни чланак artigo científico (publicado na 2011) artigo científico (publicado na 2011) мақолаи илмӣ 2011年論文 ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ bài báo khoa học artikull shkencor 2011 թվականի փետրվարին հրատարակված գիտական հոդված 2011年论文 artykuł naukowy мақолаи илмӣ artigo científico 2011年论文 bilimsel makale научна статия teaduslik artikkel מאמר מדעי 2011年论文 scienca artikolo naučni članak articol științific سائنسی مضمون 2011年論文 2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած 2011年論文 مقالة علمية artículu científicu espublizáu en 2011 vitskapeleg artikkel tudományos cikk wetenschappelijk artikel vedecký článok
p:P577
wds:Q33821379-3E31FA96-6879-4B54-8BCA-392344092759
wdt:P577
2011-02-15T00:00:00Z
p:P2888
wds:Q33821379-37CC9201-0694-4EC6-B157-43117A2BA713
wdt:P2888
n11:1471-244x-11-28
p:P2860
wds:Q33821379-93D025D1-CB09-43D1-88DE-17CF8231C469 wds:Q33821379-A5F7BB36-E2C9-4CCE-AFB0-03B1560BC060 wds:Q33821379-C503F261-1B6C-4D5C-816E-2E954076CE24 wds:Q33821379-7F2FDA58-1B4A-46E8-8E69-70314F5870B2 wds:Q33821379-891F534F-6137-425B-B175-15CF90BD0FE4 wds:Q33821379-FE2F1EE1-769D-4BAF-B712-22E8B0B52F72 wds:Q33821379-2455E11E-6168-4ED7-BE0E-7972F233C289 wds:Q33821379-62630C63-B436-484C-8B9A-DF5BED549465 wds:Q33821379-6B414560-4D20-488A-ACF1-61123B921D23 wds:Q33821379-5AFA89ED-94C2-4BF4-88F2-A5F02E93864F wds:Q33821379-1F4EF4B5-54D1-4608-B427-A345423B5E57 wds:Q33821379-2202DFBF-4A8E-4179-9DBB-9277804DC322
wdt:P2860
wd:Q35820327 wd:Q46013607 wd:Q34594237 wd:Q33554238 wd:Q43622360 wd:Q37572026 wd:Q39430904 wd:Q27860959 wd:Q37626863 wd:Q43222678 wd:Q36095391 wd:Q46615047
p:P2093
wds:Q33821379-49F9171C-8D82-4575-A5A9-4FA021EB8815 wds:Q33821379-5794C3C5-0E4E-4B89-B68C-2F115E9F7A58 wds:Q33821379-5496C0CB-BCF0-4244-BF99-AECE294BC8AE wds:Q33821379-F0ABE3F6-4E08-424A-AD95-4A19968C4619 wds:Q33821379-0A76CBDB-928F-4533-9F10-EFE0522F8BC0
wdt:P2093
Angela L Hill Susan B Watson Jamie L Karagianis David P McDonnell Bin Sun
rdfs:label
Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia
skos:prefLabel
Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia
schema:name
Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia
p:P1476
wds:Q33821379-7F1372D6-C6C1-4FEC-A40A-EFF5808B6D98
wdt:P1476
Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia
p:P304
wds:Q33821379-FE7E80CC-5ECC-4F2E-8074-266ABDD0A3C7
wdt:P304
28
p:P31
wds:Q33821379-4A738A62-B952-44A3-803F-5C7CE3B1D5BA
wdt:P31
wd:Q13442814
p:P921
wds:Q33821379-0793EF5A-CDF9-4CA8-A0F5-E7CA7F531B19
wdt:P921
wd:Q41112
p:P698
wds:Q33821379-4C7C02F5-6142-40A0-B6BE-E3B7E4EFDC9B
wdtn:P698
n12:21324135
wdt:P698
21324135
p:P1433
wds:Q33821379-8941A809-A347-4AB0-8D82-62F5A0D7DDF7
wdt:P1433
wd:Q15750257
p:P478
wds:Q33821379-B509BF99-CA12-4E65-8D39-CA77E23AF271
wdt:P478
11
p:P356
wds:Q33821379-D0B3F5CF-5D8C-4903-B77A-8C4517B2A7CE
wdtn:P356
n6:1471-244X-11-28
wdt:P356
10.1186/1471-244X-11-28
p:P275
wds:Q33821379-67b85966-c28e-47d2-8368-cf5047ec6a4e
p:P6216
wds:Q33821379-8627c582-7ec2-4426-b098-114a88016085
wdt:P275
wd:Q19125117
wdt:P6216
wd:Q50423863
p:P5875
wds:Q33821379-4A4C77BE-625C-4782-9C2D-DD4E9FE72898
wdt:P5875
49838812
p:P6179
wds:Q33821379-23CFCEC3-2073-451D-BA59-088DCBC7EFF2
wdt:P6179
1004864708
p:P932
wds:Q33821379-40AC24F4-4072-4F4F-AA6F-4DAD7EC63682
wdt:P932
3048520